World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
38092
World Ranking
9966
National Ranking
964

Dave Singh publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Dave Singh sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 769 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Dave Singh D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Dave Singh sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Dave Singh is affiliated with the University of Manchester in the United Kingdom and works extensively in the field of Medicine, with a strong focus on Pulmonary and Respiratory Medicine. Their research also spans related subfields such as Physiology, Immunology, Emergency Medical Services, and Infectious Diseases.

The primary topics that characterize Dave Singh's scientific work include:

  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Respiratory Support and Mechanisms
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Pediatric health and respiratory diseases
  • IL-33, ST2, and ILC Pathways

Singh has contributed frequently to several well-known publication venues, including:

  • American Journal of Respiratory and Critical Care Medicine
  • Respiratory Research
  • European Respiratory Journal
  • CHEST Journal
  • International Journal of COPD

The scientist has collaborated regularly with other researchers in the field. Frequent co-authors of Singh's work include Alberto Papi, Fernando J. Martínez, David Halpin, MeiLan K. Han, and Klaus F. Rabe.

Notable recent papers associated with Dave Singh include:

  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, European Respiratory Journal
  • Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease, 2020, American Journal of Respiratory and Critical Care Medicine
  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, American Journal of Respiratory and Critical Care Medicine
  • Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD, 2020, New England Journal of Medicine
  • Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial, 2020, The Lancet Respiratory Medicine

Best Publications

  • Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

    Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio Anzueto

  • Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

    Dave Singh;Alvar Agusti;Antonio Anzueto;Peter J. Barnes

  • Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

    David A. Lipson;Frank Barnhart;Noushin Brealey;Jean Brooks

  • The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines

    Julie E. Gibbs;John Blaikley;Stephen Beesley;Laura Matthews

  • Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

    David M G Halpin;Gerard J Criner;Alberto Papi;Dave Singh

  • Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.

    Alberto Papi;Jørgen Vestbo;Leonardo Fabbri;Leonardo Fabbri;Massimo Corradi

  • Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease

    Salman H. Siddiqui;Alessandro Guasconi;Jørgen Vestbo;Paul Jones

  • Eosinophilic inflammation in COPD: prevalence and clinical characteristics

    Dave Singh;Umme Kolsum;Chris E. Brightling;Nicholas Locantore

  • Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

    Dave Singh;Alberto Papi;Massimo Corradi;Ilona Pavlišová

  • Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.

    Jørgen Vestbo;Jørgen Vestbo;Alberto Papi;Massimo Corradi;Viktor Blazhko

  • Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.

    Phillip D Monk;Richard J Marsden;Victoria J Tear;Jody Brookes

  • Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

    Klaus F. Rabe;Fernando J. Martinez;Gary T. Ferguson;Chen Wang

  • Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS) : baseline data from a prospective cohort study

    Dirkje S Postma;Chris Brightling;Simonetta Baldi;Maarten Van den Berge

  • Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD

    Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio R Anzueto

  • Benralizumab for the Prevention of COPD Exacerbations

    Gerard J. Criner;Bartolome R. Celli;Christopher E. Brightling;Alvar Agusti

  • Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.

    David M.G. Halpin;Dave Singh;Ruth M. Hadfield

  • The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial.

    Ratko Djukanović;Tim Harrison;Sebastian L. Johnston;Flic Gabbay

  • Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management

    Prescott G Woodruff;Alvar Agusti;Nicolas Roche;Dave Singh

  • Superiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD

    Dave Singh;Jean Brooks;Gerry Hagan;Anthony Cahn

  • Efficacy and safety of twice-daily aclidinium bromide in COPD patients: The ATTAIN study

    Paul W Jones;Dave Singh;Eric D Bateman;Alvar Agusti

Frequent Co-Authors

Jørgen Vestbo
Jørgen Vestbo University of Manchester
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Peter Lange
Peter Lange University of Copenhagen
Alberto Papi
Alberto Papi University of Ferrara
Mark T. Dransfield
Mark T. Dransfield University of Alabama at Birmingham
Christopher E. Brightling
Christopher E. Brightling University of Leicester
David A. Lomas
David A. Lomas University College London
Jadwiga A. Wedzicha
Jadwiga A. Wedzicha Imperial College London
MeiLan K. Han
MeiLan K. Han University of Michigan–Ann Arbor
Gerard J. Criner
Gerard J. Criner Temple University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Medicine, online nursing and healthcare degrees offer flexible options to start or advance your career. Many reputable universities now offer nurse practitioner programs online, allowing you to step into advanced clinical roles while studying at your own pace.

For those with a non-nursing bachelor’s degree, cheapest online accelerated bsn programs can provide a faster route to becoming a registered nurse. These accelerated tracks combine rigorous coursework with practical clinical experience in a shorter time-frame.

Registered nurses (RNs) can further their careers with rn to bsn online programs, which are designed for working professionals. These programs help nurses acquire advanced skills, qualify for higher positions, and potentially increase earnings.

For future educators or leaders in healthcare, online nursing phd programs provide the opportunity to influence practice, policy, and research at the highest academic level—all online.

Best Scientists Citing Dave Singh

Trending Scientists

Recently Published Articles